Friday 7 November 2008

Buy Lupin, target of Rs 935: Karvy

Karvy Stock Broking has recommended a buy rating on Lupin with a target price of Rs 935 in its November 7, 2008 research report. "The company's revenues for the quarter have moved up by 38% to Rs 9.3 billion. The domestic formulation revenues have grown by 24 % to Rs 3.03 billion while formulations exports remain the fulcrum of growth with growth of 143 % to Rs 3.8 billion."

"At the current market price of Rs 25.35, the stock is trading at a P/E of 10.71x FY10E earnings of Rs. 2.37 and P/BV 0.64x FY 10E book value of Rs 39.61. We are upgrading our FY 2009 revenues by 4.3 % to Rs 36.7 bn and our FY 2010 revenues by 3.6 % to Rs 42.1 billion on account of greater traction in formulations exports especially in the regulated markets. We upgrade our FY 2009 nos by 8.1 % to Rs 53.6 and our FY 2010 nos by 12.2 % to Rs 62.3 on account of EBDITA margin expansion mainly on back of savings in gross margins and other expenses. We upgrade our price target by 6 % to Rs 935 based on 15x FY 2010E. Buy," says Karvy's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Source: Moneycontrol

No comments:

Post a Comment

DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.